Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
S. Magesh, A. Hurley, J. Nepper, M. Chevrette, J. H. Schrope, C. Li, D. J. Beebe, J. Handelsman
This study identifies genes in Flavobacterium johnsoniae critical for surface colonization in both solitary and community settings using a model microbial community.
bioRxiv · Jan 5, 2024Microbiology
L. T. Collins, W. Beatty, B. Moyo, M. Alves-Bezerra, A. Hurley, Q. Lou, Z. H. Zhou, W. Lagor, G. Bao, S. Ponnazhagan, R. McNally, L. Rome, D. Curiel
This study encapsulates AAVs into protein vault nanoparticles to bypass neutralizing antibodies, enabling effective gene therapy despite preexisting immunity.
bioRxiv · Nov 29, 2023 · PreprintBioengineering
D. S. Juang, W. E. Wightman, G. L. Lozano, L. J. Barkal, J. Yu, M. F. Garavito, A. Hurley, O. S. Venturelli, J. Handelsman, D. J. Beebe
The paper introduces a Microbial Community Interaction device to systematically study chemical and biological interactions in microbial communities, revealing antagonistic effects of gentamicin and vancomycin and community-level growth impacts.
bioRxiv · Oct 17, 2022Microbiology
Z. Wang, F. Schmidt, Y. Weisblum, F. Muecksch, C. O. Barnes, S. Finkin, D. Schaefer-Babajew, M. Cipolla, C. Gaebler, J. A. Lieberman, T. Y. Oliveira, Z. Yang, M. E. Abernathy, K. E. Huey-Tubman, A. Hurley, , M. C. Nussenzweig
This study examines antibody and memory B cell responses to mRNA vaccines against SARS-CoV-2 and assesses their effectiveness against emerging variants.
Nature · Feb 10, 2021Peer-reviewedImmunology
G. Breton, P. Mendoza, T. Hagglof, T. Y. Oliveira, D. Schaefer-Babajew, C. Gaebler, M. Turroja, A. Hurley, M. Caskey, M. C. Nussenzweig
The paper shows that SARS-CoV-2 infection leads to persistent, functional memory T cell responses and enduring immune alterations in CD4+ and CD8+ T cells six months post-infection.
bioRxiv · Dec 8, 2020Immunology
C. Gaebler, Z. Wang, J. C. C. Lorenzi, F. Muecksch, S. Finkin, M. Tokuyama, A. Cho, M. Jankovic, D. Schaefer-Babajew, T. Y. Oliveira, M. Cipolla, C. Viant, C. O. Barnes, A. Hurley, M. Turroja, , R. Patel
This study examines the evolution of antibody immunity to SARS-CoV-2 over time, finding that memory B cells evolve with increased potency and resistance to mutations.
bioRxiv · Nov 3, 2020Immunology
C. O. Barnes, A. P. West, K. Huey-Tubman, M. A. G. Hoffmann, N. G. Sharaf, P. R. Hoffman, N. Koranda, H. B. Gristick, C. Gaebler, F. Muecksch, J. C. Cetrulo Lorenzi, S. Finkin, T. Hagglof, A. Hurley, K. G. Millard, , P. J. Bjorkman
bioRxiv · May 28, 2020Immunology
D. F. Robbiani, C. Gaebler, F. Muecksch, J. Cetrulo Lorenzi, Z. Wang, A. Cho, M. Agudelo, C. Barnes, S. Finkin, T. Hagglof, T. Oliveira, C. Viant, A. Hurley, K. Millard, R. Kost, , Nuss
The paper analyzes antibody responses in convalescent individuals, finding low neutralizing titers but rare potent RBD-specific antibodies with broad antiviral potential.
bioRxiv · May 13, 2020Immunology
G. L. Lozano, J. I. Bravo, M. F. Garavito Diago, H. B. Park, A. Hurley, S. B. Peterson, E. V. Stabb, J. M. Crawford, N. A. Broderick, J. Handelsman
The paper introduces THOR, a model rhizosphere microbiome composed of three dominant taxa, to study community behavior through genetic dissection and emergent properties.
bioRxiv · Dec 19, 2018Microbiology
E. J. Contijoch, G. J. Britton, C. Yang, I. Mogno, Z. Li, R. Ng, S. R. Llewellyn, S. Hira, C. Johnson, K. M. Rabinowitz, R. Barkan, I. Dotan, R. P. Hirten, S.-C. Fu, Y. Luo, , C
The paper examines factors influencing gut microbiota density across mammals, disease states, and interventions, finding host and microbial factors shape density and impact health.
bioRxiv · Jul 12, 2018Microbiology